@article{41034ed1f6b44608a52f56ee75a52608,
title = "Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability",
keywords = "AML, CD44, CXCR2, FLT3, MIF, NFKB2, compensation, cytokine, gilteritinib, tyrosine kinase inhibitor",
author = "Huynh Cao and Verena Tadros and Benjamin Hiramoto and Kevin Leeper and Christopher Hino and Jeffrey Xiao and Bryan Pham and Kim, {Do Hyun} and Reeves, {Mark E.} and Chen, {Chien Shing} and Zhong, {Jiang F.} and Zhang, {Ke K.} and Linglin Xie and Samiksha Wasnik and Baylink, {David J.} and Yi Xu",
note = "Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2022",
month = may,
doi = "10.3390/biomedicines10051038",
language = "English",
volume = "10",
journal = "Biomedicines",
issn = "2227-9059",
number = "5",
}